Myositis‐specific anti‐155/140 autoantibodies target transcription intermediary factor 1 family proteins
Manabu Fujimoto(Osaka Gakuin University), Kazuhiko Takehara(Kanazawa University), Akira Higashi(Red Cross Hospital), Eriko Mabuchi(Japan Community Healthcare Organization), Naohito Hatta(Toyama Prefectural Central Hospital), Ikuko Ueda‐Hayakawa(Osaka City University), Yuki Ichimura(Kanazawa University), Atsuyuki Igarashi(NTT Medical Center), Minoru Hasegawa(University of Fukui), Yasuhito Hamaguchi(Kanazawa University), Keita Fujikawa(Nagasaki University), Naoko Ishiguro(Tokyo Women's Medical University), Masanari Kodera(Chukyo Hospital), Takashi Matsushita(Kanazawa University), Takuya Miyagi(Kochi Medical School Hospital), Narihiro Akimoto(Hiroshima City Asa Citizens Hospital), Kenji Hirose(Shionogi (Japan)), Kiyohiro Tsutsui(Ishikawa Prefectural Central Hospital), Kenzo Kaji(Kanazawa University), Mariko Seishima(Asahi University), Fumihide Ogawa(Nagasaki University), Yoshihide Asano(Tohoku University)
Cited by 303
Related Papers
A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory Responses
|Immunity|2008|1.2k
Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression
|Journal of Clinical Investigation|2008|907
Idiopathic inflammatory myopathies
|Nature Reviews Disease Primers|2021|683
Connective Tissue Growth Factor Gene Expression in Tissue Sections From Localized Scleroderma, Keloid, and Other Fibrotic Skin Disorders
|Journal of Investigative Dermatology|1996|438